Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
TORONTO, Oct. 22, 2025 /CNW/ - Health Canada has approved Dupixent® (dupilumab injection) as an add-on maintenance treatment in adult patients with chronic obstructive pulmonary disease (COPD) ...
Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic ...
This approval was based on findings from two clinical studies conducted in adult patients already receiving maximal standard-of-care inhaled therapy. The BOREAS and NOTUS studies showed a 30% and 34% ...
Gov. Gavin Newsom announced on Thursday that the first state-made insulin would be available at the start of 2026.California’s CalRx® Insulin Glargine in 3mL pen form will be $55 per five-pack. That's ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...
Over the last few years, the interest in GLP-1 drugs for weight loss has skyrocketed. Currently, the most common delivery system for GLP-1 medications is through pre-filled injection pens designed to ...
A new start-up — launched by some longtime beauty players — wants to make corticosteroid acne injections more accessible. Called Indomo, the company has developed an at-home mode of delivery for the ...
(Reuters) -Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its eczema treatment, Dupixent, and cancer treatment Libtayo, sending ...
Share on Pinterest The “golden dose” left in Mounjaro or Ozempic pens may do more harm than good, according to experts. Design by MNT; Photography by Bloomberg/Getty Images Over the last few years, ...
Shares rose after a jump in sales of the blockbuster Dupixent drug and robust pharmaceutical launches delivered higher revenue and adjusted earnings. Safran Raises Outlook, Forecasts Residual Tariff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results